Vijaya Diagnostic Centre Limited announced its financial results for the quarter ended September 30, 2026. The company reported a robust 26.7% year-on-year revenue growth, reaching ₹2,553.9 million. This growth was driven by a 16.5% increase in total tests and an 8.8% rise in average realization per test. Profit after tax also saw a significant jump of 37.4% to ₹594.7 million.
Vijaya Diagnostic Centre Reports Strong Q2 FY27 Performance
Vijaya Diagnostic Centre Limited (NSE: VIJAYA, BSE: 543350) has announced its consolidated financial results for the second quarter and the first half of the financial year 2027. The company demonstrated strong momentum, achieving a 26.7% year-on-year revenue growth for the quarter, amounting to ₹2,553.9 million, compared to ₹2,015.6 million in Q2 FY26. This performance was supported by a healthy 16.5% volume growth.
Key Financial Highlights
The company’s EBITDA grew by 37.8% to ₹1,127.5 million in Q2 FY27, with the EBITDA margin expanding by 355 basis points to 44.1%. Profit After Tax (PAT) surged by 37.4% to ₹594.7 million, while PAT margin improved to 23.3%. For the first half of FY27, revenue grew by 24.8% to ₹4,863.7 million, and PAT increased by 37.5% to ₹1,125.7 million.
Operational Performance
Operational highlights reveal a significant increase in Total Tests, which grew by 16.5% to 4.98 million in Q2 FY27. Total Footfall also saw a rise of 14.5% to 1.37 million. The average realization per test increased by 8.8% to ₹513, and average realization per footfall rose by 10.6% to ₹1,865.
Strategic Expansion and Outlook
Ms. Suprita Reddy, MD & CEO, commented on the results, noting that existing centres grew by approximately 20%, while newer centres are ramping up effectively. The company is focused on expanding its network, having commissioned 2 hubs and 7 spokes in H1 FY27, with plans to commission another 3 hubs and 7 spokes in H2 FY27. Additionally, the company entered into a Business Transfer Agreement to acquire Arya Wellness Centre, marking an entry into the North-East region.
Source: BSE
